A 16-year-old boy with T-cell acute lymphoblastic leukemia received induction (vincristine, prednisone, pegylated asparaginase, and daunorubicin) and consolidation chemotherapy (systemic and intrathecal methotrexate, cytarabine, 6-mercaptopurine, vincristine, pegylated asparaginase, and nelarabine). He achieved complete remission and proceeded to total body irradiation, fludarabine, and cyclophosphamide with an unrelated double cord stem cell transplant. He received cyclosporine as prophylaxis against graft vs host disease and acyclovir as prophylaxis against herpetic infections. Three weeks later, he developed retrograde and anterograde amnesia, visual hallucinations, and insomnia. He was found to be intermittently confused with staring spells. He reported brief episodes of visual hallucinations consisting of déjà-vu, sometimes accompanied by a perception that objects would gradually recede and become smaller (teleopsia). Mini-Mental State Examination was notable for impaired recall of objects at 5 minutes despite preserved registration. He had impaired concentration and attention and was only able to follow simple requests of up to 3 steps. The remainder of the neurologic examination was normal. EEG showed no epileptic discharges but intermittent, medium amplitude 4 to 5 Hz polymorphic activity of the left hemisphere, predominantly in sleep. MRI showed increased fluid-attenuated inversion recovery signal in the medial temporal lobes (figure, A-C). Cyclosporine level was 1,190 ng/mL, having been between 93 and 253 ng/mL over the last week (normal range 100-400 ng/mL).Cyclosporine was held and the next morning cyclosporine level was 265 ng/mL and remained in a therapeutic range without improvement in the patient's condition. Levetiracetam was started with resolution of visual hallucinations and staring spells. Serum PCR titers of human herpesvirus-6 (HHV-6) peaked at 118,000 copies/mL while the patient was encephalopathic. Serum testing for Epstein-Barr virus, varicella zoster virus, cytomegalovirus, and herpes simplex virus was negative. CSF was not obtained due to thrombocytopenia. A presumptive diagnosis of HHV-6 encephalitis was made. Foscarnet therapy (60 mg/kg) was initiated, with immediate decline in serum HHV-6 levels. The patient made a full recovery over the next week, but remained amnestic for most events of the preceding days. Subsequent MRI 3 months later ( figure, D) showed chronic gliotic changes in the medial right temporal